The UK life sciences sector contributes £94 billion to the economy each year, but it faces increasing global competition, alongside internal challenges such as low numbers of NHS clinical trials, and slow regulatory approval processes. Here, Professor Alejandro Frangi outlines how in silico technologies – Artificial Intelligence and other computer-based approaches for virtual product development and testing – can maintain the UK’s leadership in life sciences innovation and clinical tri...| Policy@Manchester Articles
Human embryo models are created from stem cells and provide opportunities to study early embryo development in ways that would generally be impermissible if real human embryos were used. Here, Dr Jonathan Lewis and Professor Soren Holm argue that with human embryo models becoming more advanced, regulations governing human embryo research need to be established to allow regulators, researchers, and funders to assess whether certain models should be considered as human embryos.| Policy@Manchester Articles